Health Canada Approves Zoetis’ Portela for Feline OA Pain
PARSIPPANY, N.J., December 5, 2025 — Zoetis Inc. announced that Health Canada has approved Portela™ (relfovetmab injection) for the...
Portela
Advertisement
Zoetis Secures EU Approval for New Monoclonal Antibody Therapy in Cats
Parsippany, New Jersey / Brussels, October 29, 2025 — Zoetis Inc. today announced that the European Commission has granted...
Advertisement
